The Effect of FDA Advisories on Branded Pharmaceutical Firms' Valuations and Promotion Efforts

doi 10.3386/w17528
Full Text
Abstract

Available in full text

Date
Authors
Publisher

National Bureau of Economic Research

Related search

Jingoism in Pharmaceutical Promotion

BMJ
1989English

Effect of Working Capital Management of the Profitability of Listed Pharmaceutical Firms in Nigeria

Scholars Bulletin
2019English

The Impact of Takeovers on the Acquiring Firms in the Pharmaceutical Market

Journal of Competitiveness
2017English

Pharmaceutical Promotion and GP Prescription Behaviour

SSRN Electronic Journal
2004English

The Impact of Absorptive Capacity on the Innovation Performance of Pharmaceutical Firms

English

Internationalization Strategies of Chinese Pharmaceutical Firms

International Journal of Asian Business and Information Management
ManagementBusinessInternational ManagementStrategyComputer Science ApplicationsCultural StudiesInnovationManagement of Technology
2013English

Authors’ Reply to Comment by Tailor Et. Al on “Academic Cosmetic Gynecology and Energy-Based Therapies: Ambiguities, Explorations, and FDA Advisories”

International Urogynecology Journal
GynecologyUrologyObstetrics
2019English

The Report: Promotion of Social Contributions of Research on Clinical Pharmacy and Pharmaceutical Sciences

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Risky Business: Should the FDA Pay Attention to Pharmaceutical Prices?

SSRN Electronic Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy